Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Oscar Health Inc (NYSE: OSCR) closed at $13.84 in the last session, up 1.91% from day before closing price of $13.58. In other words, the price has increased by $1.91 from its previous closing price. On the day, 13.5 million shares were traded. OSCR stock price reached its highest trading level at $14.12 during the session, while it also had its lowest trading level at $13.44.
Ratios:
We take a closer look at OSCR’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
On July 15, 2025, UBS Downgraded its rating to Sell which previously was Neutral but kept the price unchanged to $11.
Piper Sandler Downgraded its Overweight to Neutral on July 14, 2025, while the target price for the stock was maintained at $14.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 20 ’25 when RANMALI BOPITIYA bought 30,000 shares for $18.77 per share.
ALESSANDREA QUANE bought 148,280 shares of OSCR for $2,598,488 on May 16 ’25. On May 12 ’25, another insider, Robinson Elbert O. Jr., who serves as the Director of the company, sold 25,000 shares for $16.43 each. As a result, the insider received 410,750 and left with 64,512 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OSCR now has a Market Capitalization of 3524729600 and an Enterprise Value of 894478080. As of this moment, Oscar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 49.68. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.37. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.35 while its Price-to-Book (P/B) ratio in mrq is 2.63. Its current Enterprise Value per Revenue stands at 0.089 whereas that against EBITDA is 4.475.
Stock Price History:
The Beta on a monthly basis for OSCR is 1.86, which has changed by -0.19674987 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, OSCR has reached a high of $23.79, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is -11.96%, while the 200-Day Moving Average is calculated to be -8.26%.
Shares Statistics:
According to the various share statistics, OSCR traded on average about 23.91M shares per day over the past 3-months and 31650590 shares per day over the past 10 days. A total of 217.98M shares are outstanding, with a floating share count of 180.17M. Insiders hold about 29.26% of the company’s shares, while institutions hold 61.91% stake in the company. Shares short for OSCR as of 1752537600 were 62481112 with a Short Ratio of 2.61, compared to 1749772800 on 29748645. Therefore, it implies a Short% of Shares Outstanding of 62481112 and a Short% of Float of 31.759999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The dynamic stock of Oscar Health Inc (OSCR) is currently attracting attention from 3.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.56, with high estimates of -$0.5 and low estimates of -$0.62.
Analysts are recommending an EPS of between -$1.17 and -$1.42 for the fiscal current year, implying an average EPS of -$1.31. EPS for the following year is $0.15, with 5.0 analysts recommending between $0.98 and -$0.48.
Revenue Estimates
According to 7 analysts, the current quarter’s revenue is expected to be $2.92B. It ranges from a high estimate of $3.06B to a low estimate of $2.76B. As of the current estimate, Oscar Health Inc’s year-ago sales were $2.22BFor the next quarter, 7 analysts are estimating revenue of $3.07B. There is a high estimate of $3.15B for the next quarter, whereas the lowest estimate is $2.96B.
A total of 7 analysts have provided revenue estimates for OSCR’s current fiscal year. The highest revenue estimate was $12.13B, while the lowest revenue estimate was $11.71B, resulting in an average revenue estimate of $12.01B. In the same quarter a year ago, actual revenue was $9.18BBased on 7 analysts’ estimates, the company’s revenue will be $11.28B in the next fiscal year. The high estimate is $12.69B and the low estimate is $10.22B.
